154 related articles for article (PubMed ID: 19403314)
1. New antituberculotics originated from salicylanilides with promising in vitro activity against atypical mycobacterial strains.
Imramovský A; Vinsová J; Férriz JM; Dolezal R; Jampílek J; Kaustová J; Kunc F
Bioorg Med Chem; 2009 May; 17(10):3572-9. PubMed ID: 19403314
[TBL] [Abstract][Full Text] [Related]
2. [Relation between chemical structure and antimycobacterial activity against atypical strains. XIII. Thiosalicylanilides].
Waisser K; Kubicová L; Gregor J; Budová J; Andrlová A; Drsata J; Odlerová Z
Ceska Slov Farm; 1998 Mar; 47(2):84-6. PubMed ID: 9650366
[TBL] [Abstract][Full Text] [Related]
3. Salicylanilide carbamates: antitubercular agents active against multidrug-resistant Mycobacterium tuberculosis strains.
Férriz JM; Vávrová K; Kunc F; Imramovský A; Stolaríková J; Vavríková E; Vinsová J
Bioorg Med Chem; 2010 Feb; 18(3):1054-61. PubMed ID: 20060303
[TBL] [Abstract][Full Text] [Related]
4. The oriented development of antituberculotics: salicylanilides.
Waisser K; Matyk J; Divisová H; Husáková P; Kunes J; Klimesová V; Kaustová J; Möllmann U; Dahse HM; Miko M
Arch Pharm (Weinheim); 2006 Nov; 339(11):616-20. PubMed ID: 17048291
[TBL] [Abstract][Full Text] [Related]
5. Relationship between the structure and antimycobacterial activity of substituted salicylanilides.
Waisser K; Bures O; Holý P; Kunes J; Oswald R; Jirásková L; Pour M; Klimesová V; Kubicová L; Kaustová J
Arch Pharm (Weinheim); 2003 Mar; 336(1):53-71. PubMed ID: 12666254
[TBL] [Abstract][Full Text] [Related]
6. N-benzylsalicylthioamides: highly active potential antituberculotics.
Dolezal R; Waisser K; Petrlíková E; Kunes J; Kubicová L; Machácek M; Kaustová J; Dahse HM
Arch Pharm (Weinheim); 2009 Feb; 342(2):113-9. PubMed ID: 19137534
[TBL] [Abstract][Full Text] [Related]
7. The oriented development of antituberculotics (Part II): halogenated 3-(4-alkylphenyl)-1,3-benzoxazine-2,4-(3H)-diones.
Waisser K; Matyk J; Divisová H; Husáková P; Kunes J; Klimesová V; Palát K; Kaustová J
Arch Pharm (Weinheim); 2007 May; 340(5):264-7. PubMed ID: 17516578
[TBL] [Abstract][Full Text] [Related]
8. [Antimicrobial salicylanilides and 3-phenyl-2H-1,3-benzoxazine-2,4(3H)-diones].
Waisser K; Gregor J; Holý P; Kubicová L; Klimesová V; Kaustová J
Ceska Slov Farm; 2001 May; 50(3):148-52. PubMed ID: 11394023
[TBL] [Abstract][Full Text] [Related]
9. [Azabischalcones--a new class of potential antitubercular agents].
Kozmík V; Lhoták P; Odlerová Z; Palecek J
Ceska Slov Farm; 1998 Mar; 47(2):87-90. PubMed ID: 9650367
[TBL] [Abstract][Full Text] [Related]
10. Salicylanilide esters of N-protected amino acids as novel antimicrobial agents.
Imramovský A; Vinsová J; Férriz JM; Buchta V; Jampílek J
Bioorg Med Chem Lett; 2009 Jan; 19(2):348-51. PubMed ID: 19081718
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationships of antitubercular salicylanilides consistent with disruption of the proton gradient via proton shuttling.
Lee IY; Gruber TD; Samuels A; Yun M; Nam B; Kang M; Crowley K; Winterroth B; Boshoff HI; Barry CE
Bioorg Med Chem; 2013 Jan; 21(1):114-26. PubMed ID: 23211970
[TBL] [Abstract][Full Text] [Related]
12. New amino acid esters of salicylanilides active against MDR-TB and other microbes.
Krátký M; Vinšová J; Buchta V; Horvati K; Bösze S; Stolaříková J
Eur J Med Chem; 2010 Dec; 45(12):6106-13. PubMed ID: 20937542
[TBL] [Abstract][Full Text] [Related]
13. Salicylanilide pyrazinoates inhibit in vitro multidrug-resistant Mycobacterium tuberculosis strains, atypical mycobacteria and isocitrate lyase.
Krátký M; Vinšová J; Novotná E; Stolaříková J
Eur J Pharm Sci; 2014 Mar; 53():1-9. PubMed ID: 24333643
[TBL] [Abstract][Full Text] [Related]
14. Preparation and in vitro evaluation of benzylsulfanyl benzoxazole derivatives as potential antituberculosis agents.
Klimesová V; Kocí J; Waisser K; Kaustová J; Möllmann U
Eur J Med Chem; 2009 May; 44(5):2286-93. PubMed ID: 18694614
[TBL] [Abstract][Full Text] [Related]
15. Novel salicylanilides from 4,5-dihalogenated salicylic acids: Synthesis, antimicrobial activity and cytotoxicity.
Paraskevopoulos G; Monteiro S; Vosátka R; Krátký M; Navrátilová L; Trejtnar F; Stolaříková J; Vinšová J
Bioorg Med Chem; 2017 Feb; 25(4):1524-1532. PubMed ID: 28126437
[TBL] [Abstract][Full Text] [Related]
16. Antimycobacterial assessment of Salicylanilide benzoates including multidrug-resistant tuberculosis strains.
Krátký M; Vinšová J; Stolaříková J
Molecules; 2012 Oct; 17(11):12812-20. PubMed ID: 23114617
[TBL] [Abstract][Full Text] [Related]
17. Antimycobacterial activity of salicylanilide benzenesulfonates.
Krátký M; Vinšová J; Rodriguez NG; Stolaříková J
Molecules; 2012 Jan; 17(1):492-503. PubMed ID: 22222908
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, biological evaluation, and structure-activity relationships for 5-[(E)-2-arylethenyl]-3-isoxazolecarboxylic acid alkyl ester derivatives as valuable antitubercular chemotypes.
Pieroni M; Lilienkampf A; Wan B; Wang Y; Franzblau SG; Kozikowski AP
J Med Chem; 2009 Oct; 52(20):6287-96. PubMed ID: 19757815
[TBL] [Abstract][Full Text] [Related]
19. 1,5-Diphenylpyrrole derivatives as antimycobacterial agents. Probing the influence on antimycobacterial activity of lipophilic substituents at the phenyl rings.
Biava M; Porretta GC; Poce G; De Logu A; Saddi M; Meleddu R; Manetti F; De Rossi E; Botta M
J Med Chem; 2008 Jun; 51(12):3644-8. PubMed ID: 18494459
[TBL] [Abstract][Full Text] [Related]
20. [Antitubercular agents. 45. Antimycobacterial thiohydrazide].
Waisser K; Odlerová Z; Houngbedji N; Thiel W; Mayer R
Zentralbl Mikrobiol; 1989; 144(5):355-7. PubMed ID: 2515678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]